Alphanox to Acquire Additional Shares of U.S. Subsidiary for 5.6 Billion KRW
Alphanox announced on the 19th that it will acquire an additional 4 million shares of its U.S. implant sales subsidiary (Solco Biomedical) for approximately 5.6 billion KRW.
After the acquisition, Alphanox's ownership stake will become 100%. The scheduled date of share acquisition is the 23rd.
Hot Picks Today
!["I Almost Missed Out on Hundreds of Thousands of Won... I Was the Only One Who Didn't Know" How to Find Hidden Government Benefits [The Essentials of Benefits]](https://cwcontent.asiae.co.kr/asiaresize/93/2026052915221681901_1780035736.png)
"I Almost Missed Out on Hundreds of Thousands of Won... I Was the Only One Who Didn't Know" How to Find Hidden Government Benefits [The Essentials of Benefits]
- Paying $5 a Month to See Ads Unchanged?... Meta’s $12 Billion Experiment [Weekend Money]
- "Big Gains for Holders... Up 566% and Still More to Go" Target Price Raised, But Here’s Why Caution Remains [Weekend Money]
- 'Former Chungju Man' Kim Seontae Gives 10-Year-Old Car to Father with Sick Child... The Reason He Accepted Only 2,500 Won
- "Best Homeroom Teacher"... Hong Kong Education Sector in Shock Over Spread of "Princess Carry" Photos
The company stated that the purpose of this acquisition is to strengthen business competitiveness in the U.S. market and to improve its financial structure.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Land Is Pricier Than the Stock"... Stocks Making a Comeback These Days [Weekend Money]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052816231080420_1779952990.png)
